Clinical Trial Update: SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating SHR-1501 in combination with SHR-2005 for high-risk non-muscle invasive bladder cancer not completely resectable by TUR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• SHR-1501
• SHR-2005

Snippet

Sponsor: Fudan University | Conditions: NMIBC | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING